$QURE
uniQure N.V.

2024 Q4 Form 10-Q Financial Statement

#000155837024014346 Filed on November 05, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $2.287M
YoY Change 62.54%
Cost Of Revenue $264.0K
YoY Change -73.76%
Gross Profit $2.023M
YoY Change 404.49%
Gross Profit Margin 88.46%
Selling, General & Admin $11.58M
YoY Change -35.96%
% of Gross Profit 572.17%
Research & Development $30.60M
YoY Change -53.22%
% of Gross Profit 1512.36%
Depreciation & Amortization $2.986M
YoY Change 14.32%
% of Gross Profit 147.6%
Operating Expenses $42.17M
YoY Change -49.48%
Operating Profit -$40.23M
YoY Change -50.87%
Interest Expense -$4.181M
YoY Change -127.07%
% of Operating Profit
Other Income/Expense, Net $1.915M
YoY Change 739.91%
Pretax Income -$44.41M
YoY Change -50.46%
Income Tax -$31.00K
% Of Pretax Income
Net Earnings -$44.38M
YoY Change -50.45%
Net Earnings / Revenue -1940.45%
Basic Earnings Per Share -$0.91
Diluted Earnings Per Share -$0.91
COMMON SHARES
Basic Shares Outstanding 48.74M 48.70M
Diluted Shares Outstanding 48.72M

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $435.2M
YoY Change -33.95%
Cash & Equivalents $251.6M
Short-Term Investments $183.6M
Other Short-Term Assets $23.58M
YoY Change 35.36%
Inventory $0.00
Prepaid Expenses $19.29M
Receivables $5.322M
Other Receivables $0.00
Total Short-Term Assets $464.1M
YoY Change -33.09%
LONG-TERM ASSETS
Property, Plant & Equipment $25.57M
YoY Change -44.36%
Goodwill $24.08M
YoY Change -4.7%
Intangibles
YoY Change
Long-Term Investments $28.26M
YoY Change
Other Assets $1.453M
YoY Change -75.86%
Total Long-Term Assets $181.7M
YoY Change 2.1%
TOTAL ASSETS
Total Short-Term Assets $464.1M
Total Long-Term Assets $181.7M
Total Assets $645.8M
YoY Change -25.9%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.441M
YoY Change -2.56%
Accrued Expenses $32.30M
YoY Change 13.63%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $71.27M
YoY Change 3.89%
LONG-TERM LIABILITIES
Long-Term Debt $51.11M
YoY Change -49.61%
Other Long-Term Liabilities $8.919M
YoY Change 716.01%
Total Long-Term Liabilities $518.7M
YoY Change -2.89%
TOTAL LIABILITIES
Total Short-Term Liabilities $71.27M
Total Long-Term Liabilities $518.7M
Total Liabilities $590.0M
YoY Change -2.12%
SHAREHOLDERS EQUITY
Retained Earnings -$1.057B
YoY Change 29.31%
Common Stock $2.932M
YoY Change 1.7%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $55.82M
YoY Change
Total Liabilities & Shareholders Equity $645.8M
YoY Change -25.9%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income -$44.38M
YoY Change -50.45%
Depreciation, Depletion And Amortization $2.986M
YoY Change 14.32%
Cash From Operating Activities -$36.60M
YoY Change -194.05%
INVESTING ACTIVITIES
Capital Expenditures $380.0K
YoY Change -77.86%
Acquisitions
YoY Change
Other Investing Activities $48.05M
YoY Change -115.38%
Cash From Investing Activities $47.67M
YoY Change -115.18%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -53.02M
YoY Change 595.33%
NET CHANGE
Cash From Operating Activities -36.60M
Cash From Investing Activities 47.67M
Cash From Financing Activities -53.02M
Net Change In Cash -41.95M
YoY Change -85.17%
FREE CASH FLOW
Cash From Operating Activities -$36.60M
Capital Expenditures $380.0K
Free Cash Flow -$36.98M
YoY Change -199.41%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
47833830
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
48738874
dei Entity Central Index Key
EntityCentralIndexKey
0001590560
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
00-0000000
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-36294
dei Entity Registrant Name
EntityRegistrantName
uniQure N.V.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
P7
dei Entity Address Address Line1
EntityAddressAddressLine1
Paasheuvelweg 25
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
1105 BP
dei Entity Address City Or Town
EntityAddressCityOrTown
Amsterdam
dei Entity Address Country
EntityAddressCountry
NL
dei City Area Code
CityAreaCode
31
dei Local Phone Number
LocalPhoneNumber
20-240-6000
dei Security12b Title
Security12bTitle
Ordinary Shares, par value €0.05
dei Trading Symbol
TradingSymbol
QURE
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
48743140
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
251626000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
241360000
CY2024Q3 us-gaap Debt Securities Held To Maturity Amortized Cost After Allowance For Credit Loss Current
DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLossCurrent
183615000
CY2023Q4 us-gaap Debt Securities Held To Maturity Amortized Cost After Allowance For Credit Loss Current
DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLossCurrent
376532000
CY2024Q3 qure Accounts Receivable And Contract With Customer Asset Current
AccountsReceivableAndContractWithCustomerAssetCurrent
5322000
CY2023Q4 qure Accounts Receivable And Contract With Customer Asset Current
AccountsReceivableAndContractWithCustomerAssetCurrent
4193000
CY2023Q4 us-gaap Inventory Net
InventoryNet
12024000
CY2024Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
19286000
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
15089000
CY2024Q3 qure Other Current Assets And Receivables
OtherCurrentAssetsAndReceivables
4289000
CY2023Q4 qure Other Current Assets And Receivables
OtherCurrentAssetsAndReceivables
2655000
CY2024Q3 us-gaap Assets Current
AssetsCurrent
464138000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
651853000
CY2024Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
30800000
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
55700000
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
25566000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
46548000
CY2024Q3 us-gaap Other Investments
OtherInvestments
28260000
CY2023Q4 us-gaap Other Investments
OtherInvestments
2179000
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
14833000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
28789000
CY2024Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
76609000
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
60481000
CY2024Q3 us-gaap Goodwill
Goodwill
24084000
CY2023Q4 us-gaap Goodwill
Goodwill
26379000
CY2024Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
10863000
CY2023Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
12276000
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1453000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3184000
CY2024Q3 us-gaap Assets Noncurrent
AssetsNoncurrent
181668000
CY2023Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
179836000
CY2024Q3 us-gaap Assets
Assets
645806000
CY2023Q4 us-gaap Assets
Assets
831689000
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
5441000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
6586000
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
32301000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
30534000
CY2024Q3 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
29233000
CY2023Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
28211000
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
4298000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
8344000
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
71273000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
73675000
CY2024Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
51113000
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
101749000
CY2024Q3 qure Liability From Royalty Financing Agreement Non Current
LiabilityFromRoyaltyFinancingAgreementNonCurrent
426687000
CY2023Q4 qure Liability From Royalty Financing Agreement Non Current
LiabilityFromRoyaltyFinancingAgreementNonCurrent
394241000
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
12185000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
28316000
CY2024Q3 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
12181000
CY2023Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
14795000
CY2024Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
7627000
CY2023Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
7543000
CY2024Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
8919000
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3700000
CY2024Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
518712000
CY2023Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
550344000
CY2024Q3 us-gaap Liabilities
Liabilities
589985000
CY2023Q4 us-gaap Liabilities
Liabilities
624019000
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.05
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.05
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
48738874
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
47833830
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
47833830
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
2932000
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
2883000
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1166291000
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1148749000
CY2024Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-56698000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-53553000
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1056704000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-890409000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
55821000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
207670000
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
645806000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
831689000
CY2024Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
2287000
CY2023Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1407000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
21898000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
9154000
CY2024Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
264000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
648000
CY2024Q3 qure Cost Of Contract Manufacturing Revenues
CostOfContractManufacturingRevenues
757000
CY2023Q3 qure Cost Of Contract Manufacturing Revenues
CostOfContractManufacturingRevenues
1006000
qure Cost Of Contract Manufacturing Revenues
CostOfContractManufacturingRevenues
17060000
qure Cost Of Contract Manufacturing Revenues
CostOfContractManufacturingRevenues
4793000
CY2024Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
30595000
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
65400000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
104942000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
172245000
CY2024Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
11575000
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
18074000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
41279000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
57103000
CY2024Q3 us-gaap Costs And Expenses
CostsAndExpenses
43191000
CY2023Q3 us-gaap Costs And Expenses
CostsAndExpenses
84480000
us-gaap Costs And Expenses
CostsAndExpenses
163929000
us-gaap Costs And Expenses
CostsAndExpenses
234141000
CY2024Q3 us-gaap Other Income
OtherIncome
2591000
CY2023Q3 us-gaap Other Income
OtherIncome
1424000
us-gaap Other Income
OtherIncome
5950000
us-gaap Other Income
OtherIncome
4537000
CY2024Q3 us-gaap Other Expenses
OtherExpenses
1915000
CY2023Q3 us-gaap Other Expenses
OtherExpenses
228000
us-gaap Other Expenses
OtherExpenses
2385000
us-gaap Other Expenses
OtherExpenses
673000
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-40228000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-81877000
us-gaap Operating Income Loss
OperatingIncomeLoss
-138466000
us-gaap Operating Income Loss
OperatingIncomeLoss
-221123000
CY2024Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
4866000
CY2023Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
7495000
us-gaap Investment Income Interest
InvestmentIncomeInterest
17179000
us-gaap Investment Income Interest
InvestmentIncomeInterest
12393000
CY2024Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
16611000
CY2023Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
15444000
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
48865000
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
25846000
CY2024Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
7564000
CY2023Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
186000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
5430000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-1809000
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-44409000
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-89640000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-164722000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-236385000
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-31000
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-69000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1573000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1113000
CY2024Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-44378000
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-89571000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-166295000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-235272000
CY2024Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-415000
CY2023Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-6118000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-3252000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-267000
CY2024Q3 us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
-37000
us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
-107000
CY2024Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-44756000
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-95689000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-169440000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-235539000
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.91
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.91
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.88
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.88
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.42
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.42
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-4.94
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-4.94
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48718533
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
48718533
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
47770101
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
47770101
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48576339
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
48576339
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
47619875
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
47619875
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
353320000
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-89571000
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-6118000
CY2023Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2000
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
11097000
CY2023Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
54000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
268784000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
97107000
CY2024Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-44378000
CY2024Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-378000
CY2024Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
32000
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3438000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
55821000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
476009000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-235272000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-267000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
123000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
28052000
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
139000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
268784000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
207670000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-166295000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-3145000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
32000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
17509000
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
50000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
55821000
us-gaap Profit Loss
ProfitLoss
-166295000
us-gaap Profit Loss
ProfitLoss
-235272000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
8285000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
7712000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
-8472000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
-6529000
us-gaap Share Based Compensation
ShareBasedCompensation
17509000
us-gaap Share Based Compensation
ShareBasedCompensation
28052000
qure Royalty Financing Agreement Interest Expense
RoyaltyFinancingAgreementInterestExpense
37671000
qure Royalty Financing Agreement Interest Expense
RoyaltyFinancingAgreementInterestExpense
14940000
qure Deferred Income Tax Expense Benefit With Adjustments
DeferredIncomeTaxExpenseBenefitWithAdjustments
1573000
qure Deferred Income Tax Expense Benefit With Adjustments
DeferredIncomeTaxExpenseBenefitWithAdjustments
-1113000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-2032000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
15441000
us-gaap Inventory Write Down
InventoryWriteDown
6297000
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
5726000
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-3119000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
2460000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-2146000
qure Increase Decrease In Accounts Receivable And Contract Assets Prepaid Expenses And Other Current Assets And Receivables
IncreaseDecreaseInAccountsReceivableAndContractAssetsPrepaidExpensesAndOtherCurrentAssetsAndReceivables
5764000
qure Increase Decrease In Accounts Receivable And Contract Assets Prepaid Expenses And Other Current Assets And Receivables
IncreaseDecreaseInAccountsReceivableAndContractAssetsPrepaidExpensesAndOtherCurrentAssetsAndReceivables
-96551000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3876000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
8730000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-512000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-4784000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-6082000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-6007000
us-gaap Payment For Contingent Consideration Liability Operating Activities
PaymentForContingentConsiderationLiabilityOperatingActivities
1914000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-129884000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-96388000
us-gaap Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities
480806000
us-gaap Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities
106307000
us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
279586000
us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
366439000
qure Payments For Divestiture Of Businesses
PaymentsForDivestitureOfBusinesses
8300000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3328000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5116000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
189592000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-265248000
qure Proceeds From Royalty Financing Agreement
ProceedsFromRoyaltyFinancingAgreement
374350000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
4288000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
81000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
262000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
53050000
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
7649000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-52969000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
362675000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1796000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
424000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
8535000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1463000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
244544000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
231173000
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
253079000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
232636000
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
251626000
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
229484000
CY2024Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
1453000
CY2023Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
3152000
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
253079000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
232636000
us-gaap Interest Paid Net
InterestPaidNet
16892000
us-gaap Interest Paid Net
InterestPaidNet
12996000
qure Increase Decrease In Accounts Payable And Accrued Liabilities Related To Non Current Assets
IncreaseDecreaseInAccountsPayableAndAccruedLiabilitiesRelatedToNonCurrentAssets
-673000
qure Increase Decrease In Accounts Payable And Accrued Liabilities Related To Non Current Assets
IncreaseDecreaseInAccountsPayableAndAccruedLiabilitiesRelatedToNonCurrentAssets
-995000
us-gaap Nature Of Operations
NatureOfOperations
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">1</b></span>General business information</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;">uniQure N.V. (the “Company”) was incorporated on January 9, 2012, as a private company with limited liability (<i style="font-style:italic;">besloten vennootschap met beperkte aansprakelijkheid</i>) under the laws of the Netherlands. The Company is a leader in the field of gene therapy and seeks to deliver to patients suffering from rare and other devastating diseases single treatments with potentially curative results. The Company’s business was founded in 1998 and was initially operated through its predecessor company, Amsterdam Molecular Therapeutics Holding N.V. (“AMT”). In 2012, AMT undertook a corporate reorganization, pursuant to which uniQure B.V. acquired the entire business and assets of AMT and completed a share-for-share exchange with the shareholders of AMT. Effective February 10, 2014, in connection with its initial public offering, the Company converted into a public company with limited liability (<i style="font-style:italic;">naamloze vennootschap</i>) and changed its legal name from uniQure B.V. to uniQure N.V.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 1pt 0pt 1pt;"><span style="margin-left:0pt;margin-right:0pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;">The Company is registered in the trade register of the Dutch Chamber of Commerce (<i style="font-style:italic;">Kamer van Koophandel</i>) in Amsterdam, the Netherlands under number 54385229. The Company’s headquarters are in Amsterdam, the Netherlands, and its registered office is located at Paasheuvelweg 25a, Amsterdam 1105 BP, the Netherlands and its telephone number is +31 20 240 6000.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;">The Company’s ordinary shares are listed on the Nasdaq Global Select Market and trade under the symbol “QURE”.</p>
CY2023 qure Reclassification From Other Non Current Assets To Other Investments
ReclassificationFromOtherNonCurrentAssetsToOtherInvestments
2200000
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">2.3</b></span><b style="font-weight:bold;">Use of estimates </b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;">The preparation of the financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p>
CY2024Q3 us-gaap Business Exit Costs1
BusinessExitCosts1
1400000
CY2024Q3 us-gaap Severance Costs1
SeveranceCosts1
4100000
CY2024Q3 us-gaap Severance Costs1
SeveranceCosts1
4084000
us-gaap Severance Costs1
SeveranceCosts1
5515000
CY2023Q4 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
1000000.0
CY2023Q4 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
1027000
us-gaap Severance Costs1
SeveranceCosts1
5515000
us-gaap Payments For Restructuring
PaymentsForRestructuring
2444000
CY2024Q3 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
4098000
CY2024Q3 us-gaap Debt Securities Held To Maturity Amortized Cost After Allowance For Credit Loss Current
DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLossCurrent
183615000
CY2024Q3 qure Debt Securities Current Held To Maturity Accumulated Unrecognized Gain
DebtSecuritiesCurrentHeldToMaturityAccumulatedUnrecognizedGain
250000
CY2024Q3 us-gaap Debt Securities Current
DebtSecuritiesCurrent
183865000
CY2023Q4 us-gaap Debt Securities Held To Maturity Amortized Cost After Allowance For Credit Loss Current
DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLossCurrent
376532000
CY2023Q4 qure Debt Securities Current Held To Maturity Accumulated Unrecognized Gain
DebtSecuritiesCurrentHeldToMaturityAccumulatedUnrecognizedGain
139000
CY2023Q4 us-gaap Debt Securities Current
DebtSecuritiesCurrent
376671000
CY2024Q3 qure Investment Securities With Original Maturities Of Less Than90 Days When Purchased And Presented Within Cash And Cash Equivalents At Amortized Cost
InvestmentSecuritiesWithOriginalMaturitiesOfLessThan90DaysWhenPurchasedAndPresentedWithinCashAndCashEquivalentsAtAmortizedCost
44600000
CY2023Q4 qure Investment Securities With Original Maturities Of Less Than90 Days When Purchased And Presented Within Cash And Cash Equivalents At Amortized Cost
InvestmentSecuritiesWithOriginalMaturitiesOfLessThan90DaysWhenPurchasedAndPresentedWithinCashAndCashEquivalentsAtAmortizedCost
0
CY2023Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
7157000
CY2023Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
4109000
CY2023Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
758000
CY2023Q4 us-gaap Inventory Net
InventoryNet
12024000
CY2024Q3 us-gaap Inventory Write Down
InventoryWriteDown
500000
us-gaap Inventory Write Down
InventoryWriteDown
6300000
us-gaap Inventory Write Down
InventoryWriteDown
0
CY2023Q3 us-gaap Inventory Write Down
InventoryWriteDown
0
CY2024Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
0
CY2023Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
1600000
CY2024Q3 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
29200000
CY2023Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
28200000
CY2024Q3 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
41400000
CY2023Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
43000000.0
CY2024Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
15438000
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
16263000
CY2024Q3 qure Accruals For Services Provided By Vendors Not Yet Billed Current
AccrualsForServicesProvidedByVendorsNotYetBilledCurrent
12350000
CY2023Q4 qure Accruals For Services Provided By Vendors Not Yet Billed Current
AccrualsForServicesProvidedByVendorsNotYetBilledCurrent
12834000
CY2024Q3 qure Long Term Purchase Commitments Liability Current
LongTermPurchaseCommitmentsLiabilityCurrent
2428000
CY2024Q3 us-gaap Other Accounts Payable And Accrued Liabilities
OtherAccountsPayableAndAccruedLiabilities
2085000
CY2023Q4 us-gaap Other Accounts Payable And Accrued Liabilities
OtherAccountsPayableAndAccruedLiabilities
1437000
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
32301000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
30534000
CY2023Q4 us-gaap Other Accounts Payable And Accrued Liabilities
OtherAccountsPayableAndAccruedLiabilities
1400000
CY2024Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
3200000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
3500000
CY2024Q3 qure Share Based Compensation Arrangement By Share Based Payment Award Number Of Milestones Achieved
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfMilestonesAchieved
3
CY2024Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.001
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.010
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.258
CY2023Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.001
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.005
CY2024Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7577384
CY2023Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8164211
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7577384
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8164211
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 qure Non Rule10b51 Arr Modified Flag
NonRule10b51ArrModifiedFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q3 qure Rule10b51 Arr Modified Flag
Rule10b51ArrModifiedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001558370-24-014346-index-headers.html Edgar Link pending
0001558370-24-014346-index.html Edgar Link pending
0001558370-24-014346.txt Edgar Link pending
0001558370-24-014346-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
qure-20240930.xsd Edgar Link pending
qure-20240930x10q.htm Edgar Link pending
qure-20240930xex31d1.htm Edgar Link pending
qure-20240930xex31d2.htm Edgar Link pending
qure-20240930x10q_htm.xml Edgar Link completed
qure-20240930xex32d1.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
qure-20240930_cal.xml Edgar Link unprocessable
qure-20240930_def.xml Edgar Link unprocessable
qure-20240930_lab.xml Edgar Link unprocessable
qure-20240930_pre.xml Edgar Link unprocessable
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable